Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway
Authors
Keywords
-
Journal
CELL CYCLE
Volume 12, Issue 18, Pages 3109-3124
Publisher
Informa UK Limited
Online
2013-09-24
DOI
10.4161/cc.26173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy in stem cells
- (2013) Jun-Lin Guan et al. Autophagy
- Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity
- (2013) Fang Wu et al. BMC CANCER
- The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells
- (2013) JAVIER MENENDEZ et al. CELL CYCLE
- The mitochondrial H+-ATP synthase and the lipogenic switch
- (2013) Alejandro Vazquez-Martin et al. CELL CYCLE
- CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches
- (2013) Karin Williams et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Energy metabolism and energy-sensing pathways in mammalian embryonic and adult stem cell fate
- (2013) V. A. Rafalski et al. JOURNAL OF CELL SCIENCE
- Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT–MET mechanism for optimal reprogramming
- (2013) Xiaopeng Liu et al. NATURE CELL BIOLOGY
- Characterization of pluripotent stem cells
- (2013) Mercè Martí et al. Nature Protocols
- Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors
- (2013) M Nishi et al. ONCOGENE
- Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer
- (2013) Y.-L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Energy metabolism plasticity enables stemness programs
- (2012) Clifford D.L. Folmes et al. Annals of the New York Academy of Sciences
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
- (2012) Marina Kolesnichenko et al. CELL CYCLE
- Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells
- (2012) Alejandro Vazquez-Martin et al. CELL CYCLE
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
- (2012) Brandon Faubert et al. Cell Metabolism
- Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity
- (2012) Fang Wu et al. CELLULAR SIGNALLING
- Connecting mTORC1 signaling to SREBP-1 activation
- (2012) Inan Bakan et al. CURRENT OPINION IN LIPIDOLOGY
- The Link between the Metabolic Syndrome and Cancer
- (2012) Sandra Braun et al. International Journal of Biological Sciences
- Breast-cancer stem cells—beyond semantics
- (2012) Sunil Badve et al. LANCET ONCOLOGY
- Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer
- (2012) P R Pandey et al. ONCOGENE
- Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming
- (2012) X Zhang et al. ONCOGENE
- An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state
- (2012) C. Polytarchou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Elaborate Regulation of Mammalian Target of Rapamycin Activity Is Required for Somatic Cell Reprogramming Induced by Defined Transcription Factors
- (2012) Jing He et al. STEM CELLS AND DEVELOPMENT
- Induced Pluripotency and Oncogenic Transformation Are Related Processes
- (2012) John W. Riggs et al. STEM CELLS AND DEVELOPMENT
- iPSCs from cancer cells: challenges and opportunities
- (2012) Verónica Ramos-Mejia et al. TRENDS IN MOLECULAR MEDICINE
- Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency
- (2012) Alejandro Vazquez-Martin et al. Scientific Reports
- Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
- (2012) Atsushi Sato et al. Stem Cells Translational Medicine
- Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency
- (2011) Sergio Menendez et al. AGING CELL
- Sensing of energy and nutrients by AMP-activated protein kinase
- (2011) D Grahame Hardie AMERICAN JOURNAL OF CLINICAL NUTRITION
- Energy metabolism in nuclear reprogramming
- (2011) Clifford DL Folmes et al. Biomarkers in Medicine
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Transcriptional Control of Cellular Metabolism by mTOR Signaling
- (2011) J. L. Yecies et al. CANCER RESEARCH
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
- (2011) Timothy R. Peterson et al. CELL
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
- (2011) Piyush B. Gupta et al. CELL
- The Lin28/let-7 Axis Regulates Glucose Metabolism
- (2011) Hao Zhu et al. CELL
- mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: A roadmap from energy metabolism to stem cell renewal and aging
- (2011) Javier A. Menendez et al. CELL CYCLE
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
- (2011) Jessica L. Yecies et al. Cell Metabolism
- Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear Reprogramming
- (2011) Clifford D.L. Folmes et al. Cell Metabolism
- The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming
- (2011) Athanasia D Panopoulos et al. CELL RESEARCH
- Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape
- (2011) Bernadett Papp et al. CELL RESEARCH
- Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells
- (2011) C. Visus et al. CLINICAL CANCER RESEARCH
- E-cadherin, a new mixer in the Yamanaka cocktail
- (2011) William E Lowry EMBO REPORTS
- E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming
- (2011) Torben Redmer et al. EMBO REPORTS
- AMP-activated protein kinase--an energy sensor that regulates all aspects of cell function
- (2011) D. G. Hardie GENES & DEVELOPMENT
- Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
- (2011) Phuc V Pham et al. Journal of Translational Medicine
- miR-495 is upregulated by E12/E47 in breast cancer stem cells and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1
- (2011) W W Hwang-Verslues et al. ONCOGENE
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion
- (2011) F Yu et al. ONCOGENE
- Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts
- (2011) Sandra Varum et al. PLoS One
- Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
- (2011) D. Iliopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
- (2010) Puspa R. Pandey et al. BREAST CANCER RESEARCH AND TREATMENT
- The Origins and Implications of Intratumor Heterogeneity
- (2010) F. Michor et al. Cancer Prevention Research
- Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues
- (2010) Jacob H. Hanna et al. CELL
- A Mesenchymal-to-Epithelial Transition Initiates and Is Required for the Nuclear Reprogramming of Mouse Fibroblasts
- (2010) Ronghui Li et al. Cell Stem Cell
- Derivation of human embryonic stem cells at the Center of Regenerative Medicine in Barcelona
- (2010) Begoña Aran et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Insulin analogues and cancer risk: cause for concern orcause célèbre?
- (2010) M. Pollak et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Resveratrol Inhibits mTOR Signaling by Promoting the Interaction between mTOR and DEPTOR
- (2010) Meilian Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid
- (2010) Roberta Malaguarnera et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?
- (2010) Malcolm R Alison et al. JOURNAL OF PATHOLOGY
- Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer
- (2010) S Peng et al. ONCOGENE
- Physiological cellular reprogramming and cancer
- (2010) Fernando Abollo-Jiménez et al. SEMINARS IN CANCER BIOLOGY
- Cancer as a reprogramming-like disease: Implications in tumor development and treatment
- (2010) Andrés Castellanos et al. SEMINARS IN CANCER BIOLOGY
- The Senescence-Related Mitochondrial/Oxidative Stress Pathway is Repressed in Human Induced Pluripotent Stem Cells
- (2010) Alessandro Prigione et al. STEM CELLS
- DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
- (2009) Timothy R. Peterson et al. CELL
- The role of p53 in limiting somatic cell reprogramming
- (2009) Yan Liu et al. CELL RESEARCH
- Linking the p53 tumour suppressor pathway to somatic cell reprogramming
- (2009) Teruhisa Kawamura et al. NATURE
- A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
- (2009) Rosa M. Marión et al. NATURE
- Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
- (2009) Jochen Utikal et al. NATURE
- The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells
- (2009) Barak Blum et al. NATURE BIOTECHNOLOGY
- Defined factors induce reprogramming of gastrointestinal cancer cells
- (2009) N. Miyoshi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative Medicine
- (2009) Paul S. Knoepfler STEM CELLS
- Octamer 4 Small Interfering RNA Results in Cancer Stem Cell-Like Cell Apoptosis
- (2008) T. Hu et al. CANCER RESEARCH
- Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
- (2008) Madhuri Kakarala et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
- (2008) Trond Aasen et al. NATURE BIOTECHNOLOGY
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More